Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.
about
A chemocentric approach to the identification of cancer targetsStromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancerEnhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice.Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study.A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesisCyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort studyImmunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: a clinicopathological study.Estrogen receptor beta as target for colorectal cancer preventionEstrogen receptors and human disease: an update.A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem Cells.Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?Sex-dependent differences in intestinal tumorigenesis induced in Apc1638N/+ mice by exposure to γ rays.Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling.ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis.The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice.Significance of intratissue estrogen concentration coupled with estrogen receptors levels in colorectal cancer prognosis.Chemopreventive effect of ERβ-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors
P2860
Q28482507-DE2CAAC8-36F8-44F9-9318-081CFC1066A4Q33833367-22B2F595-8E68-453A-A3A6-D4166B2FDB1DQ34103959-765A23E8-7CBB-435F-9308-C1BEAD8C985BQ34514971-FF72FF4C-0B32-419D-9D6D-037155AEF975Q34804602-3EAAE3FD-C648-45F2-9CCD-0FD7F4EAAD16Q35231140-14B34F06-626D-4401-B648-012708FFC38CQ35548020-E4161085-5850-4992-8D66-4393A6564EBFQ36553757-214D5393-69C6-4A78-B7FB-D6327C8C2627Q36661810-F78A6226-FAC0-4E9B-A592-D31A22E3C6ADQ36678829-9B424F55-A8AC-4CB6-AB61-4C9F47399BD0Q36682613-85B6A5B7-08A1-4991-A194-9E90C6E2905CQ36946119-2C8C77A1-79AE-4035-A114-2D0E00325B1EQ37412030-34A0F0C0-5B4C-47F3-A67E-063142DFB66AQ38416668-5D45B5CD-CA3F-4A00-A713-5BAE8333E317Q46329425-6CA4A258-E778-4465-A44E-7510AAD66885Q49569216-78A7D3BB-B719-4162-88E0-7C09BA6BAEA4Q51478367-D5D60A13-2C18-4564-954F-3C307E32E54FQ57655214-47E7831B-9E9E-4313-97BD-D38A1F357D66
P2860
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc
@nl
Disruption of estrogen recepto ...... neoplasia in Apc(Min/+) mice.
@en
type
label
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc
@nl
Disruption of estrogen recepto ...... neoplasia in Apc(Min/+) mice.
@en
prefLabel
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc
@nl
Disruption of estrogen recepto ...... neoplasia in Apc(Min/+) mice.
@en
P2093
P2860
P50
P356
P1433
P1476
Disruption of estrogen recepto ...... neoplasia in Apc(Min/+) mice.
@en
P2093
Alicia G Cleveland
Dennis B Lubahn
Henry C Pitot
Joseph J Rafter
Karen A Gould
Kimberly K Bynoté
Maija Marttinen
Marja Mutanen
Shyamal K Roy
P2860
P304
P356
10.1093/CARCIN/BGP132
P407
P577
2009-06-11T00:00:00Z